Pediatric Rheumatology

pediatric rheumatology banner

Latest News

Examining Gaps in Mental Health Care Among Youth With Juvenile Rheumatic Disease

Examining Gaps in Mental Health Care Among Youth With Juvenile Rheumatic Disease

There is an unmet need for mental health interventions that address illness-related issues affecting youth with rheumatologic conditions.

Diagnosing Lyme Disease in Children With Neuropsychiatric Illness

Diagnosing Lyme Disease in Children With Neuropsychiatric Illness

Health professionals from many disciplines need to be able to recognize the clinical presentations, essential diagnostic tests, and treatment approach of Lyme neuroborreliosis.

Low Nailfold Capillary Density Associated With Lung Involvement in Juvenile Dermatomyositis

Low Nailfold Capillary Density Associated With Lung Involvement in Juvenile Dermatomyositis

Low nailfold capillary density is associated with impaired pulmonary function tests and more frequent high-resolution computed tomography abnormalities in patients with juvenile dermatomyositis.

Novel MRI-Based Scoring System Assesses Disease Severity in Juvenile Dermatomyositis

Novel MRI-Based Scoring System Assesses Disease Severity in Juvenile Dermatomyositis

The JDM Image Score may have the potential to serve as a reliable biomarker of disease severity and response to therapeutic interventions in children with juvenile dermatomyositis.

Clinical Assessment of Juvenile Idiopathic Arthritis: Predicting Unfavorable Long-Term Outcomes

Clinical Assessment of Juvenile Idiopathic Arthritis: Predicting Unfavorable Long-Term Outcomes

Prediction models of outcomes in juvenile idiopathic arthritis have acceptable precision and require only readily available baseline variables.

Clinical Correlates of JIA Relapse After Biologic Therapy Discontinuation

Clinical Correlates of JIA Relapse After Biologic Therapy Discontinuation

The investigators sought to evaluate the time patients were in remission after discontinuing biologic therapy for the treatment of JIA.

Actemra SC Approved to Treat Polyarticular Juvenile Idiopathic Arthritis

Actemra SC Approved to Treat Polyarticular Juvenile Idiopathic Arthritis

The FDA has approved the subcutaneous formulation of Actemra for the treatment of active polyarticular juvenile idiopathic arthritis.

Depressive Symptoms Predict Future Pain, Disability in Adolescent JIA

Depressive Symptoms Predict Future Pain, Disability in Adolescent JIA

Baseline depressive symptoms were associated with pain and disability in adolescents with juvenile idiopathic arthritis.

Efficacy, Safety of Adalimumab vs Infliximab in JIA-Associated Uveitis

Efficacy, Safety of Adalimumab vs Infliximab in JIA-Associated Uveitis

Researchers evaluated the safety and efficacy of adalimumab and infliximab in the treatment of juvenile idiopathic arthritis-associated uveitis in patients treated for at least 2 years.

Amendment Added to OMERACT Ultrasound Definition of Healthy Pediatric Joints

Amendment Added to OMERACT Ultrasound Definition of Healthy Pediatric Joints

Researchers sought to include Doppler findings in the evaluation and definition of normal joint features that can be visualized in healthy children in different age groups.

Sign Up for Free e-newsletters